Administration of Mesna with a chemotherapy agent helps in?

Appeared in: Chitranjjan National Cancer Institute Kolkata - 2021

Explanation

Mesna is classified as a cytoprotective agent, specifically a uroprotectant.
It is given concurrently with chemotherapy drugs like ifosfamide and cyclophosphamide.
Its primary function is to protect the cells of the bladder lining from a toxic metabolite called acrolein.
By neutralizing acrolein in the urine, Mesna prevents the development of hemorrhagic cystitis (bladder bleeding and irritation).

Option A: Mesna does not have any anticancer properties. Its role is purely protective, not destructive to cancer cells.
Option C: Preventing the formation of uric acid is the function of drugs like Allopurinol or Rasburicase, which are used to manage tumor lysis syndrome.
Option D: Increasing the production of white blood cells (WBCs) is the role of colony-stimulating factors (CSFs) like Filgrastim (G-CSF) or Pegfilgrastim.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacology of Chemotherapy Adjunctive Agents as background academic context rather than a clinical decision trigger.
Mesna is a critical component of high-dose chemotherapy regimens involving ifosfamide or cyclophosphamide to ensure patient safety and allow for effective cancer treatment without dose-limiting bladder toxicity.
Nurses play a vital role in ensuring Mesna is administered at the correct times relative to the chemotherapy infusion and in monitoring the patient for signs of hemorrhagic cystitis, such as hematuria (blood in urine) and dysuria (painful urination).
Vigorous hydration is a key nursing intervention alongside Mesna administration to help flush the bladder and further reduce the risk of cystitis.

How to Approach the Question

First, identify the drug mentioned in the question stem, which is 'Mesna'.
Recall the pharmacological class and primary function of Mesna. It is known as a cytoprotective or uroprotective agent.
Analyze the context: it is administered 'with a chemotherapy agent'. This points to its role as an adjunctive therapy.
Evaluate each option based on the known function of Mesna.
Option A (destruction of cancer cells) is the role of chemo, not Mesna. Eliminate it.
Option B (Protecting the cells) aligns perfectly with Mesna's role as a cytoprotective agent.

Concept Tested & Keywords

Qj3t6VgU4FTb3Y3dWSyRaL

E6 Nursing Brunner Adult Health 3SA Vol 2 Part 3 p. 6-8

E6 Pharmacology KD Tripathi Essentials 9e Part 3 p. 216-218

E6 Pharmacology Nurses Shanbhag 3e p. 345-347

Practise the full Chitranjjan National Cancer Institute Kolkata - 2021

Attempt every question from this paper in a timed mock, then review the full solution for each one.